PT-141 (bremelanotide) is a metabolite of Melanotan II acting principally at the MC3R and MC4R melanocortin receptors in the central nervous system. Unlike vascular approaches, its mechanism is central — which is what makes it of interest in melanocortin pathway research. The 10mg presentation was chosen to suit the scale of work you are running.
Purity of ≥99.4% with identity confirmed by LC-MS and endotoxin testing at <0.5 EU/mg on every production batch.
The dry vial is stable at 2–8 °C away from direct light; reconstituted solution is best used within 3–4 weeks. Delivery across Indonesia using secure packaging.
For in-vitro and laboratory research use only.